S Giammarco, R Maggi, Luca Di Marino, P Chiusolo, L Teofili, N Piccirilo, E Metafuni, M A Limongiello, S Leotta, G Milone, A Cupri, I Cutini, R Saccardi, C Nozzoli, R Boncompagni, A Gozzini, B Scappini, M Piccini, N S Fracchiolla, S Sica
{"title":"BLIND研究:采用blinatumomab和DLI方法治疗异基因干细胞移植后B-ALL复发。意大利多中心经验。","authors":"S Giammarco, R Maggi, Luca Di Marino, P Chiusolo, L Teofili, N Piccirilo, E Metafuni, M A Limongiello, S Leotta, G Milone, A Cupri, I Cutini, R Saccardi, C Nozzoli, R Boncompagni, A Gozzini, B Scappini, M Piccini, N S Fracchiolla, S Sica","doi":"10.1038/s41409-024-02475-0","DOIUrl":null,"url":null,"abstract":"","PeriodicalId":9126,"journal":{"name":"Bone Marrow Transplantation","volume":" ","pages":""},"PeriodicalIF":4.5000,"publicationDate":"2024-11-21","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"The BLIND study: blinatumomab and DLI approach for management of B-ALL relapse after allogeneic stem cell transplantation. A multicentric Italian experience.\",\"authors\":\"S Giammarco, R Maggi, Luca Di Marino, P Chiusolo, L Teofili, N Piccirilo, E Metafuni, M A Limongiello, S Leotta, G Milone, A Cupri, I Cutini, R Saccardi, C Nozzoli, R Boncompagni, A Gozzini, B Scappini, M Piccini, N S Fracchiolla, S Sica\",\"doi\":\"10.1038/s41409-024-02475-0\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"\",\"PeriodicalId\":9126,\"journal\":{\"name\":\"Bone Marrow Transplantation\",\"volume\":\" \",\"pages\":\"\"},\"PeriodicalIF\":4.5000,\"publicationDate\":\"2024-11-21\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Bone Marrow Transplantation\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.1038/s41409-024-02475-0\",\"RegionNum\":2,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q1\",\"JCRName\":\"HEMATOLOGY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Bone Marrow Transplantation","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1038/s41409-024-02475-0","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"HEMATOLOGY","Score":null,"Total":0}
The BLIND study: blinatumomab and DLI approach for management of B-ALL relapse after allogeneic stem cell transplantation. A multicentric Italian experience.
期刊介绍:
Bone Marrow Transplantation publishes high quality, peer reviewed original research that addresses all aspects of basic biology and clinical use of haemopoietic stem cell transplantation.
The broad scope of the journal thus encompasses topics such as stem cell biology, e.g., kinetics and cytokine control, transplantation immunology e.g., HLA and matching techniques, translational research, and clinical results of specific transplant protocols. Bone Marrow Transplantation publishes 24 issues a year.